BrainsWay Surges with SWIFT and Expansion | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded19 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20065493

Show notes

BrainsWay’s Q2 2026 results are explosive: revenue up 35% to $17.1M, operating income soaring over 300%, signaling not just growth but smarter, more efficient scaling. They shipped 125 Deep TMS systems—bringing their installed base to nearly 2,000—with strong future revenue locked in via a 30% jump in performance obligations. Clinical momentum is key: FDA clearances, payer recognition, and the game-changing SWIFT protocol (proven durable effects lasting a full year) are accelerating adoption. They’re also expanding into complex conditions like PTSD and MDD, with over 83% of patients showing meaningful response—and an FDA submission pending. Strategically, BrainsWay is investing in behavioral health platforms and exploring home-based treatments, building a full ecosystem for interventional psychiatry beyond just one device. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a674340c2d97872d

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.